MedPath

Efficacy and safety of intermittent bolus comparing with traditional continuous drip of 3% NaCl in patients with severe symptomatic hyponatremia at Kranuan Crown Prince Hospital.

Phase 3
Recruiting
Conditions
Pateints with Severe symptomatic hyponatremia.
Severe symptomatic hyponatremia
Registration Number
TCTR20240716002
Lead Sponsor
Orakan Lanwong
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
42
Inclusion Criteria

1.Patients who are visitting at Emergency room or admitted in Kranuan Crown Prince hospital.
2.Age older than 18 years old.
3.Glucose-corrected plasma sodium less than 125 mmol per L.
4.Severe symptoms (vomiting, drowsy, seizure and coma).
5.Body weight more than or equal 45 kg.

Exclusion Criteria

1.Hypotension (systolic blood pressure less than 90 mmol per L) or mean arterial pressure less than 70 mmol per L.
2.Pregnancy or breast feeding.
3.Previous history of volume overload or congestive heart failure (CHF).
4.Patients with lung congestion from chest X-ray.
5.Chronic kidney disease with edema.
6.Cirrhosis with edema.
7.Patients with symptoms of CAD, VHD and arrythmia.
8.Patients with brain injuries or increased intracranial pressure that is not from hyponatremia.
9.Patients who have critical illness suc as respiratory failure,sepsis or multiorgan failure
10.Deny consent form.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to achieve target in pNa and improvement of Glasglow Coma Scale (GCS). at 6 hours after treatment minutes
Secondary Outcome Measures
NameTimeMethod
Changes in pNa 6 hr after treatment mEq/L ,overcorrection rate in 24th and 48 th hr percent,Osmotic demyelination rate 48 hr percent ,mortality rate 30 days percent
© Copyright 2025. All Rights Reserved by MedPath